Search Results 671-680 of 17660 for protein intake optimization

  1. Medical Research & Education - Mayo Clinic News Network

    Mayo Clinic researchers have discovered a new role that a specific protein plays in regulating cell resistance and fighting tumors in certain types of ...

  2. Neurosurgery - Clinical trials

    ... protein CMVpp65. Cohort 1 includes blood ... Optimal Immunotargeting of MUC1 for Advanced Pancreatic Cancer” (Principal Investigator Dr. ... Students · Admissions ...

  3. Neurology - Clinical trials

    The purpose of this study is to learn more about the distribution of the pathological protein tau in the living brains of patients with Progressive Supranuclear ...

  4. A Study to Evaluate Tadalafil and Lenalidomide with or without Activated Marrow Infiltrating Lymphocytes (MILs) in High Risk Myeloma - Mayo Clinic

    ... optimal dosages and risks/benefits. In the later ... Meet all institutional requirements for autologous stem cell transplantation. ... POEMS syndrome (plasma cell ...

  5. Neurosurgery - Clinical trials

    ... protein CMVpp65. Cohort 1 includes blood ... Optimal Immunotargeting of MUC1 for Advanced Pancreatic Cancer” (Principal Investigator Dr. ... Students · Admissions ...

  6. A Multi-Center Trial of the ProLung Test™ - Mayo Clinic

    Optimize and confirm the stability of the ProLung Test risk-stratification ... Subject is capable of understanding and agreeing to fulfill the requirements of ...

  7. Overview - Spatial Hybrid Core - Mayo Clinic Research Core Facilities

    Through spatial multi-omic platforms, RNA and protein detection can be ... Project request intake form. More about research at Mayo Clinic. Research ...

  8. A Study to Determine the Differences in Microbiota Composition in Patients With and Without Post-Infection Irritable Bowel Syndrome - Mayo Clinic

    ... proteins and lipids in volunteers with and without Rome IV defined Campylobacter jejuni PI-IBS. Participation eligibility. Participant eligibility includes ...

  9. Ph 1b Study to Evaluate GSK2110183 in Combination with Bortezomib and Dexamethasone in Subjects with Multiple Myeloma - Mayo Clinic

    ... optimal dosages and risks/benefits. In the later ... Capable of giving written informed consent, which includes compliance with the requirements and restrictions ...

  10. Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers - Mayo Clinic

    ... optimal dosages and risks/benefits. In the later ... requirement) (obtained =< 14 days prior to registration) - ... - Urine protein/creatinine (UPC) ratio < 1.0 at ...